From: Cardiovascular disease (CVD): assessment, prediction and policy implications
Years | Original Data | NDGM | Cumulative | RGR | RGR Mean | Dt | Mean Dt |
---|---|---|---|---|---|---|---|
2005 | 295,320 | 295,320 | 295,320 | Â | Â | Â | Â |
2006 | 298,835 | 297,535 | 594,156 | 0.699 | 0.223 | 1.051 | 2.397 |
2007 | 302,305 | 302,502 | 896,461 | 0.411 | Â | 1.582 | Â |
2008 | 307,782 | 307,896 | 1,204,244 | 0.295 | Â | 1.913 | Â |
2009 | 313,037 | 313,753 | 1,517,282 | 0.231 | Â | 2.158 | Â |
2010 | 319,323 | 320,113 | 1,836,606 | 0.191 | Â | 2.349 | Â |
2011 | 326,241 | 327,019 | 2,162,848 | 0.164 | Â | 2.504 | Â |
2012 | 334,172 | 334,517 | 2,497,021 | 0.144 | Â | 2.9 | Â |
2013 | 342,768 | 342,660 | 2,839,790 | 0.129 | Â | 2.644 | Â |
2014 | 352,846 | 351,502 | 3,192,636 | 0.117 | Â | 2.838 | Â |
2015 | 362,180 | 361,102 | 3,554,816 | 0.107 | Â | 2.924 | Â |
2016 | 372,093 | 371,527 | 3,926,909 | 0.100 | Â | 3.12 | Â |
2017 | 381,421 | 382,847 | 4,308,331 | 0.093 | Â | 3.072 | Â |
2018 | 395,139 | 399,214 | 395,139 | 0.201 | Â | 1.914 | Â |
2019 | 408,486 | 412,578 | 803,625 | 0.230 | Â | 0.351 | Â |
2020 | Â | 422,979 | 1,226,605 | Â | Â | Â | Â |
2021 | Â | 438,716 | 1,665,321 | 0.7521 | 0.265 | 1.887 | 2.125 |
2022 | Â | 455,804 | 2,121,126 | 0.212 | Â | 2.112 | Â |
2023 | Â | 474,360 | 2,595,486 | 0.252 | Â | 2.423 | Â |
2024 | Â | 494,508 | 3,089,995 | 02174 | Â | 2.521 | Â |
2025 | Â | 516,386 | 3,606,381 | 0.300 | Â | 2.656 | Â |
2026 | Â | 540,143 | 4,146,525 | 0.268 | Â | 2.721 | Â |
2027 | Â | 565,939 | 4,712,464 | 0.228 | Â | 2.905 | Â |
MAPE % | Â | 1.56 | Â | Â | Â | Â | Â |